Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2002
10/03/2002WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002WO2002077253A1 Process for producing acrylamide using microbial catalyst having been washed with aqueous acrylic acid solution
10/03/2002WO2002077246A2 Site-targeted transformation using amplification vectors
10/03/2002WO2002077244A1 Transformant producing pf1022 substance derivatives, process for producing the same and novel biosynthesis gene
10/03/2002WO2002077241A2 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/03/2002WO2002077237A2 Transporters and ion channels
10/03/2002WO2002077236A2 Compositions and methods relating to lung specific genes and proteins
10/03/2002WO2002077232A2 Compositions and methods relating to breast specific genes and proteins
10/03/2002WO2002077230A1 Nr10 splicing variants
10/03/2002WO2002077223A1 Novel aminopeptidase and its gene
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077213A2 New elongase gene and production of δ9-polyunsaturated fatty acids
10/03/2002WO2002077212A2 D-carbamoylase from arthrobacter crystallopoietes dsm 20117
10/03/2002WO2002077205A2 Culture medium for enhanced heterologous protein expression
10/03/2002WO2002077202A1 Culture medium for cell growth and transfection
10/03/2002WO2002077201A2 A method of preparing a growth substrate
10/03/2002WO2002077189A2 Glycosylation-resistant and nonglycosylated cyanovirins
10/03/2002WO2002077179A2 Leinamycin biosynthesis gene cluster and its components and their uses
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002WO2002077024A1 Shellfish protein
10/03/2002WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077005A1 Pesticidal spinosyn derivatives
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002WO2002060276A9 Combination of probiotics
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002WO2002033057A3 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002018611A3 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
10/03/2002WO2002018595A3 Moraxella polypeptides and corresponding dna fragments and uses thereof
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002008440A3 Fermentation process for epothilones
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity
10/03/2002WO2001074862A3 Method for the production of bacterial toxins
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001023526A9 Engineered radiation resistant bioremediating bacteria
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2000073502A3 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
10/03/2002WO1999064459A3 Gene encoding organic anion transporter
10/03/2002WO1999047923A3 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
10/03/2002US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria
10/03/2002US20020143163 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same, and applications thereof
10/03/2002US20020143161 Members of the d52 gene family
10/03/2002US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142959 As drugs, diagnostics, biosensors and bioreactors
10/03/2002US20020142958 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/03/2002US20020142951 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002US20020142456 Protein for use in the treatment of body weight defects
10/03/2002US20020142451 Generation of nodulation inoculant; obtain nutrient broth, mix with iron, monitor cell density factor, evaluate nodulation in propagating plants
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142425 Beta 1,3-galactosyltransferase and DNA encoding the same
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142419 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders and arthritis
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142408 Production of cyclic terpenoids
10/03/2002US20020142406 Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates
10/03/2002US20020142405 Process for the preparation of L-amino acids by fermentation and nucleotide sequences coding for the accDA gene
10/03/2002US20020142401 Isolated gene for methylmalonyl CoA epimerase and uses thereof
10/03/2002US20020142400 Production of polyketides in bacteria and yeast
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142388 Bacterial host strains
10/03/2002US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis
10/03/2002US20020142373 Tissue factor protein variants
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142363 Medical diagnosis, therapy; detecting binding of proteins
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142337 Hybrid nucleotide sequence library for use as tool in genetic engineering
10/03/2002US20020142333 Heat resistant enzymatic polypeptide for use as a tool in nucleotide sequences analysis
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142321 Method for the evolutionary design of biochemical reaction networks
10/03/2002US20020142296 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142282 Immortalized human keratinocyte cell line
10/03/2002US20020142007 Intracellular delivery vehicles
10/03/2002US20020139495 Method for decomposing polyesters containing aromatic moieties, a denier reduction method of fiber, and microorganisms having activity of decomposing the polyester
10/03/2002US20020139012 Methods for identifying modulators of N-type ion channel inactivation
10/03/2002CA2442325A1 Shellfish protein
10/03/2002CA2442254A1 Site-targeted transformation using amplification vectors
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon